Diagnostic Deals - G2 Intelligence

Dx Deals: Collaboration Takes Psoriasis Testing to New Level

Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually

Start a Free Trial for immediate access to this article

Already a member? Log in here

Both companies have made recent moves to diversify further.

Start a Free Trial for immediate access to this article

Already a member? Log in here

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

Start a Free Trial for immediate access to this article

Already a member? Log in here

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

Start a Free Trial for immediate access to this article

Already a member? Log in here

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

Start a Free Trial for immediate access to this article

Already a member? Log in here